Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors

Advances in cancer immunology have increased the use of immune checkpoint inhibitors in clinical practice, however not all patients respond, and treatment can have severe side-effects. Blood-based immunological biomarkers are an attractive method for predicting which patients will respond to therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Dart, Sarah J., Cook, Alistair M., Millward, Michael J., McDonnell, Alison M., Chin, Wee L., Hakeem, Muhammad U., Meniawy, Tarek M., Bowyer, Samantha E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319434/
https://www.ncbi.nlm.nih.gov/pubmed/34321489
http://dx.doi.org/10.1038/s41598-021-93479-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319434/
https://www.ncbi.nlm.nih.gov/pubmed/34321489
http://dx.doi.org/10.1038/s41598-021-93479-z

Ejemplares similares